Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 123Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006–2017

Neha Reddy, Subeesh Viswam, Beulah Elsa, Gouri Nair, Maheswari Eswaran

Year : 2020| Volume: 11| Issue : 1 | Page no: 24-30

   This article has been cited by
1 Risk of Guillain–Barré syndrome after vaccination against human papillomavirus: a systematic review and meta-analysis, 1 January 2000 to 4 April 2020
T Sonia Boender, Barbara Bartmeyer, Louise Coole, Ole Wichmann, Thomas Harder
Eurosurveillance. 2022; 27(4)
[Pubmed]  [Google Scholar] [DOI]
2 The Development of Human Papillomavirus (HPV) Vaccines and Current Barriers to Implementation
Rebecca Butterfield,Salimah Dhanani
Immunological Investigations. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020
Yu Hu,Xuejiao Pan,Linzhi Shen,Fuxing Chen,Ying Wang,Hui Liang,Yaping Chen,Huakun Lv
Human Vaccines & Immunotherapeutics. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Investigation on Spontaneous Abortion and Human Papillomavirus Infection
Mauro Tognon,Andrea Tagliapietra,Federica Magagnoli,Chiara Mazziotta,Lucia Oton-Gonzalez,Carmen Lanzillotti,Fortunato Vesce,Carlo Contini,John Charles Rotondo,Fernanda Martini
Vaccines. 2020; 8(3): 473
[Pubmed]  [Google Scholar] [DOI]
5 Post-approval Safety Monitoring of Quadrivalent and Bivalent Human Papillomavirus Vaccines Based on Real-world Data from the Korea Adverse Events Reporting System (KAERS)
MoonJung Kim,SangHee Kim,Ju-Young Shin
Clinical Drug Investigation. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article